Neonc Technologies Holdings, Inc. $NTHI Shares Purchased by Westmount Partners LLC

Westmount Partners LLC boosted its stake in shares of Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) by 355.2% during the 2nd quarter, Holdings Channel.com reports. The firm owned 197,178 shares of the company’s stock after acquiring an additional 153,858 shares during the period. Westmount Partners LLC’s holdings in Neonc Technologies were worth $893,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. HighPoint Advisor Group LLC boosted its stake in shares of Neonc Technologies by 20.5% in the 4th quarter. HighPoint Advisor Group LLC now owns 1,144,640 shares of the company’s stock valued at $9,466,000 after buying an additional 194,408 shares during the period. Bank of America Corp DE increased its stake in shares of Neonc Technologies by 5.0% during the first quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock worth $1,650,000 after buying an additional 11,108 shares during the period. Vanguard Group Inc. acquired a new stake in Neonc Technologies in the third quarter valued at approximately $1,279,000. 683 Capital Management LLC acquired a new stake in Neonc Technologies in the fourth quarter valued at approximately $442,000. Finally, State Street Corp lifted its stake in Neonc Technologies by 9.9% in the fourth quarter. State Street Corp now owns 43,170 shares of the company’s stock worth $357,000 after acquiring an additional 3,900 shares during the last quarter.

Neonc Technologies Stock Performance

NTHI opened at $3.50 on Friday. Neonc Technologies Holdings, Inc. has a one year low of $3.01 and a one year high of $12.99. The business’s 50-day simple moving average is $4.20 and its 200-day simple moving average is $6.28.

Neonc Technologies (NASDAQ:NTHI) last posted its earnings results on Friday, May 15th. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.16).

Analyst Ratings Changes

NTHI has been the subject of several analyst reports. BTIG Research reiterated a “buy” rating and set a $15.00 price target on shares of Neonc Technologies in a report on Tuesday, May 26th. Alliance Global Partners assumed coverage on shares of Neonc Technologies in a report on Tuesday, May 19th. They issued a “buy” rating and a $13.00 price objective on the stock. Maxim Group initiated coverage on shares of Neonc Technologies in a research report on Monday, May 18th. They set a “buy” rating and a $20.00 price objective for the company. Finally, Weiss Ratings downgraded shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, June 24th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $16.00.

Neonc Technologies Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.